High rate of recurrence of cervical intraepithelial neoplasia after surgery in HIV-positive women

Journal of Acquired Immune Deficiency Syndromes

Volumn 39, Issue 4, 2005, Pages 412-418

  Heard, Isabelle ^a   Potard, Valérie ^b   Foulot, Hervé ^c   Chapron, Charles ^c   Costagliola, Dominique ^b   Kazatchkine, Michel D ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b INSERM   (France)

^c Hôpital Cochin ^*  (France)

Author keywords

Antiretroviral therapy; Cervical intraepithelial neoplasia; HIV infected women; Surgery

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; ARTICLE; CANCER GRADING; COLPOSCOPY; CYTOLOGY; DRUG EFFICACY; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOCOMPETENCE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENCE RISK; RISK FACTOR; UTERINE CERVIX CARCINOMA IN SITU;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HIV INFECTIONS; HUMANS; NEOPLASM RECURRENCE, LOCAL; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 22344441045     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000167157.83098.60     Document Type: Article

References (30)

1. Wright T, Ellerbrock T, Chiasson M, et al. Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears. Obstet Gynecol. 1994;84: 591-597.
2. Six C, Heard I, Bergeron C, et al. Comparative prevalence, incidence and short-term prognosis of cervical squamous intraepithelial lesions amongst HIV-positive and HIV-negative women. AIDS. 1998;12:1047-1056.
3. Massad LS, Riester KA, Anastos KM. et al. Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with HIV-1. J Acquir Immune Defic Syndr. 1999;21:33-41.
4. Palefsky J, Minkoff H, Kalish L, et al. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J Natl Cancer Inst. 1999;91:226-236.
5. Stover CT, Smith DK, Schmid DS, et al. Prevalence of and risk factors for viral infections among human immunodeficiency virus (HIV)-infected and high-risk HIV-uninfected women. J Infect Dis. 2003;187:1388-1396.
6. Heard I, Tassie J-M, Schmitz V, et al. Increased risk of cervical disease among human immunodeficiency virus-infected women with severe immunosuppression and high human papillomavirus load. Obstet Gynecol. 2000;96: 403-409.
7. Massad LS, Ahdieh L, Benning L, et al. Evolution of cervical abnormalities among women with HIV-1: evidence from surveillance cytology in the women's Interagency HIV Study. J Acquir Immune Defic Syndr. 2001;27:432-442.
8. Duerr A, Kieke B, Warren D, et al. Human papillomavirus-associated cervical cytologic abnormalities among women with or at risk of infection with human immunodeficiency virus. Am J Obstet Gynecol. 2001;184: 584-590.
9. Martin-Hirsch PL, Paraskevaidis E, Kitchener H. Surgery for cervical intraepithelial neoplasia. Cochrane Database Syst Rev. 2000:CD001318.
10. Wright TC, Jr, Cox JT, Massad LS, et al. 2001 consensus guidelines for the management of women with cervical intraepithelial neoplasia. Am J Obstet Gynecol. 2003;189:295-304.
11. Mitchell MF, Tortolero-Luna G, Cook E, et al. A randomized clinical trial of cryotherapy, laser vaporization, and loop electrosurgical excision for treatment of squamous intraepithelial lesions of the cervix. Obstet Gynecol. 1998;92:737-744.
12. Wright TC, Jr, Koulos J, Schnell F, et al. Cervical intraepithelial neoplasia in women infected with the human immunodeficiency virus: outcome after loop electrosurgical excision. Gynecol Oncol. 1994;55:253-258.
13. Heard I, Bergeron C, Jeannel D, et al. Papanicolaou smears in human immunodeficiency virus-seropositive women during follow-up. Obstet Gynecol. 1995;86:749-753.
14. Fruchter RG, Maiman M, Sedlis A, et al. Multiple recurrences of cervical intraepithelial neoplasia in women with the human immunodeficiency virus. Obstet Gynecol. 1996;87:338-344.
15. Holcomb K, Matthew R, Chapman J, et al. The efficacy of cervical conization in the treatment of cervical intraepithelial neoplasia in HIV-positive women. Gynecol Oncol. 1999;74:428-431.
16. Mocroft A, Ledergerber B, Katlama C, et al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet. 2003; 362:22-29.
17. Heard I, Palefsky JM, Kazatchkine MD. The impact of HIV antiviral therapy on human papillomavirus (HPV) infections and HPV-related diseases. Antivir Ther. 2004;9:13-22.
18. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002;287: 2114-2119.
19. Richart RM. A modified terminology for cervical intraepithelial neoplasia. Obstet Gynecol. 1990;75:131-133.
20. Boardman LA, Peipert JF, Hogan JW, et al. Positive cone biopsy specimen margins in women infected with the human immunodeficiency virus. Am J Obstet Gynecol. 1999;181:1395-1399.
21. Maiman M, Fruchter RG, Serur E, et al. Recurrent cervical intraepithelial neoplasia in human immunodeficiency virus-seropositive women. Obslet Gynecol. 1993;82:170-174.
22. Tate DR, Anderson RJ. Recrudescence of cervical dysplasia among women who are infected with the human immunodeficiency virus: a case-control analysis. Am J Obstet Gynecol. 2002;186:880-882.
23. Paramsothy P, Duerr A, Heilig C, et al. Abnormal vaginal cytology in HIV-infected and at-risk women after hysterectomy. J Acquir Immune Defic Syndr. 2004;35:484-491.
24. Murdoch JB, Morgan PR, Lopes A, et al. Histological incomplete excision of CIN after large loop excision of the transformation zone (LLETZ) merits careful follow up, not retreatment. Br J Obstet Gynaecol. 1992;99:990-993.
25. Gardeil F, Barry-Walsh C, Prendiville W, et al. Persistent intraepithelial neoplasia after excision for cervical intraepithelial neoplasia grade III. Obstet Gynecol. 1997;89:419-422.
26. Paraskevaidis E, Kalantaridou SN, Paschopoulos M, et al. Factors affecting outcome after incomplete excision of cervical intraepithelial neoplasia. Eur J Gynaecol Oncol. 2003;24:541-543.
27. Robinson WR, Hamilton CA, Michaels SH, et al. Effect of excisional therapy and highly active antiretroviral therapy on cervical intraepithelial neoplasia in women infected with human immunodeficiency virus. Am J Obstet Gynecol. 2001;184:538-543.
28. Keller J, Sewell C, Trimble C, et al. Correlates of recurrent cervical dysplasia in HIV positive women after excisional treatment. Presented at: XIVth International Conference on AIDS; 2002; Barcelona.
29. Wright T, Bush T, Sawo D, et al. A clinical trial comparing standard treatment modalities for squamous intraepithelial lesions of the cervix in HIV-infected women [abstract LB 16]. Presented at: Ninth Conference on Retroviruses and Opportunistic Infections; 2002; Seattle.
30. International Collaboration on HIV and Cancer. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst. 2000;92:1823-1830.